{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:30:14Z","timestamp":1776702614373,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.yebeh.2026.111015","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:18:53Z","timestamp":1774286333000},"page":"111015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The efficacy and tolerability of lacosamide adjunctive therapy in children with drug-refractory epilepsy: A nationwide Turkish cohort study"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5726-737X","authenticated-orcid":false,"given":"Pinar Ozkan","family":"Kart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Serdaroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihal","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recep Kamil","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehpare","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suleyman","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcrsel","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pakize","family":"Karaoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irmak","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selcan","family":"Ozt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif Perihan","family":"Oncel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celil","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arife Derda","family":"Y\u00fccel \u015een","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seda","family":"Kanmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanem Keskin","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Topcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cetin","family":"Okuyaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7462-4578","authenticated-orcid":false,"given":"Coskun","family":"Yarar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kursat Bora","family":"Carman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffer","family":"Polat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilknur","family":"Erol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Canpolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"G\u00fcm\u00fcs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin","family":"Per","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Gencpinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5902-3501","authenticated-orcid":false,"given":"Nihal Olgac","family":"Dundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aycan","family":"\u00dcnalp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5432-8624","authenticated-orcid":false,"given":"B\u00fclent","family":"\u00dcnay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6mer","family":"Bekta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Teber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu\u011fba","family":"Hirfano\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru Petek","family":"Arhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kursad","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Tekgul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senay","family":"Haspolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Serdaroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Cansu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yebeh.2026.111015_b0005","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.3928\/00904481-20150203-10","article-title":"Antiepileptic drugs\u2014a review","volume":"44","author":"Sankaraneni","year":"2015","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.yebeh.2026.111015_b0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s40262-015-0276-0","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of lacosamide","volume":"54","author":"Cawello","year":"2015","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1016\/j.yebeh.2026.111015_b0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2026.111015_b0020","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.3390\/molecules25215083","article-title":"New Methods used in Pharmacokinetics and Therapeutic monitoring of the first and Newer Generations of Antiepileptic Drugs (AEDs)","volume":"25","author":"Sommerfeld-Klatta","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.yebeh.2026.111015_b0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2014.11.021","article-title":"Current understanding of the mechanism of action of the antiepileptic drug lacosamide","volume":"110","author":"Rogawski","year":"2015","journal-title":"Epilepsy Res"},{"issue":"12","key":"10.1016\/j.yebeh.2026.111015_b0030","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nrd2764","article-title":"Lacosamide","volume":"7","author":"Perucca","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.yebeh.2026.111015_b0035","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s40263-023-01029-0","article-title":"Efficacy and safety of five broad-spectrum antiseizure medications for adjunctive treatment of refractory epilepsy: a systematic review and network meta-analysis","volume":"37","author":"Wang","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2026.111015_b0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.seizure.2023.06.014","article-title":"First add-on lacosamide treatment in children with focal epilepsy in China: a multi-centre real-life cohort study","volume":"111","author":"Liu","year":"2023","journal-title":"Seizure: European J Epilepsy"},{"issue":"7","key":"10.1016\/j.yebeh.2026.111015_b0045","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/0883073816630084","article-title":"Efficacy and tolerability of lacosamide in the treatment of children with refractory generalized epilepsy","volume":"31","author":"Miskin","year":"2016","journal-title":"J Child Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2026.111015_b0050","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pediatrneurol.2010.12.003","article-title":"Experience with lacosamide in a series of children with drug-resistant focal epilepsy","volume":"44","author":"Guilhoto","year":"2011","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2026.111015_b0055","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/epi.17241","article-title":"International League against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Specchio","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111015_b0060","article-title":"Definition of sistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic strategies","author":"Kwan","year":"2010","journal-title":"Wiley Online Library"},{"issue":"6","key":"10.1016\/j.yebeh.2026.111015_b0065","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/epi.18338","article-title":"Updated classification of epileptic seizures: Position paper of the International League against Epilepsy","volume":"66","author":"Beniczky","year":"2025","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2026.111015_b0070","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111015_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.seizure.2016.01.017","article-title":"The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population","volume":"36","author":"Tekg\u00fcl","year":"2016","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.yebeh.2026.111015_b0140","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/epi.14071","article-title":"Long\u2010term efficacy of add\u2010on lacosamide treatment in children and adolescents with refractory epilepsies: a single\u2010center observational study","volume":"59","author":"Rosati","year":"2018","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2026.111015_b0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s13760-019-01098-3","article-title":"Lacosamide in patients with intellectual disability and refractory epilepsy","volume":"119","author":"Kleist","year":"2019","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"10.1016\/j.yebeh.2026.111015_b0150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jpc.14156","article-title":"Lacosamide in children with drug\u2010resistant epilepsy","volume":"55","author":"R\u00fcegger","year":"2019","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111015_b0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12887-023-04039-5","article-title":"Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.yebeh.2026.111015_b0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11636260-000000000-00000","article-title":"Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain","volume":"12","author":"Casas-Fern\u00e1ndez","year":"2012","journal-title":"Drugs R&D"},{"issue":"4","key":"10.1016\/j.yebeh.2026.111015_b0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pediatrneurol.2014.07.004","article-title":"Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy","volume":"51","author":"Pasha","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111015_b0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.seizure.2018.01.014","article-title":"Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: a systematic review","volume":"56","author":"de la Rosa","year":"2018","journal-title":"Seizure"},{"issue":"11","key":"10.1016\/j.yebeh.2026.111015_b0170","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1055\/s-0042-1758366","article-title":"Use of lacosamide in children: experience of a tertiary medical care center in Brazil","volume":"80","author":"Rom\u00e3o","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.yebeh.2026.111015_b0120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yebeh.2017.11.024","article-title":"The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting","volume":"79","author":"Sanmart\u00ed-Vilaplana","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111015_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2023.06.022","article-title":"Effect of Lacosamide on Interictal Epileptiform Discharges in Pediatric patients with newly Diagnosed Focal Epilepsy","volume":"147","author":"Hoshino","year":"2023","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111015_b0180","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2147\/NDT.S452784","article-title":"Clinical analysis of lacosamide monotherapy in the treatment of self-limited epilepsy with centrotemporal spikes","author":"Feng","year":"2024","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"10.1016\/j.yebeh.2026.111015_b0185","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ane.12221","article-title":"Efficacy and tolerability of add\u2010on lacosamide in children with L ennox\u2010G astaut syndrome","volume":"129","author":"Grosso","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2026.111015_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.seizure.2025.08.032","article-title":"Efficacy of adjunctive lacosamide in children with drug-resistant epilepsy: a systematic review, meta-analysis and meta-regression","author":"da Silva","year":"2025","journal-title":"Seizure: European J Epilepsy"},{"issue":"3","key":"10.1016\/j.yebeh.2026.111015_b0195","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/epi4.12522","article-title":"Long\u2010term safety and tolerability of lacosamide monotherapy in patients with epilepsy: results from a multicenter, open\u2010label trial","volume":"6","author":"Ben-Menachem","year":"2021","journal-title":"Epilepsia open"},{"key":"10.1016\/j.yebeh.2026.111015_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108128","article-title":"Lacosamide as first add-on or conversion monotherapy: a retrospective real-life study","volume":"122","author":"Casciato","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111015_b0205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.yebeh.2019.02.022","article-title":"Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: a retrospective study","volume":"94","author":"Del Bianco","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"02","key":"10.1016\/j.yebeh.2026.111015_b0210","first-page":"98","article-title":"Clinical observation on the curative effect of lacosamide in adjuctive treatment in children with refractory epilepsy","volume":"6","author":"Feng","year":"2020","journal-title":"J Epilepsy Res"},{"issue":"11","key":"10.1016\/j.yebeh.2026.111015_b0215","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00381-017-3586-8","article-title":"Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients","volume":"33","author":"Yildiz","year":"2017","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.yebeh.2026.111015_b0220","article-title":"Status epilepticus developing during lacosamide monotherapy","volume":"2015","author":"Papacostas","year":"2015","journal-title":"Case Reports"},{"issue":"9","key":"10.1016\/j.yebeh.2026.111015_b0095","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/epi.13466","article-title":"Lacosamide use in children with epilepsy: retention rate and effect of concomitant sodium channel blockers in a large cohort","volume":"57","author":"McGinnis","year":"2016","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111015_b0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yebeh.2010.10.002","article-title":"Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?","volume":"20","author":"Novy","year":"2011","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2026.111015_b0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1535759720928269","article-title":"Treatment of refractory convulsive status epilepticus: a comprehensive review by the American Epilepsy Society Treatments Committee","volume":"20","author":"Vossler","year":"2020","journal-title":"Epilepsy Currents"},{"issue":"10","key":"10.1016\/j.yebeh.2026.111015_b0235","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/jnnp-2020-323524","article-title":"Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial","volume":"91","author":"Vossler","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.yebeh.2026.111015_b0240","doi-asserted-by":"crossref","first-page":"e1212","DOI":"10.1212\/WNL.0000000000008126","article-title":"Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures","volume":"93","author":"Farkas","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111015_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107814","article-title":"Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur, China","volume":"117","author":"Zhao","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.yebeh.2026.111015_b0245","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14917","article-title":"Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged\u2265 1 month to\u2264 4 years: a real\u2010world study","volume":"30","author":"Yang","year":"2024","journal-title":"CNS Neurosci Ther"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026001368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026001368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:33:36Z","timestamp":1776699216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026001368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"alternative-id":["S1525505026001368"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111015","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and tolerability of lacosamide adjunctive therapy in children with drug-refractory epilepsy: A nationwide Turkish cohort study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111015"}}